Novo Nordisk Has Its Best Year Ever
The Danish group has seen the kind of profit growth that other companies can only dream of. But nothing lasts forever: its 2024 guidance looks rather more modest.
The Danish group has seen the kind of profit growth that other companies can only dream of. But nothing lasts forever: its 2024 guidance looks rather more modest.